68Ga-BNOTA-PRGD2

N/A

Report date: 2025/11/20 16:02:29
NME

Base Information

Drug Name68Ga-BNOTA-PRGD2
Drug Alias Name68Ga-p-SCN-Bn-NOTA-PEG3-RGD268Ga-NOTA-PRGD2
ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Gallium > 68Ga +[5] 
Mechanisms of ActionIntegrin alpha-V/beta-3 antagonists
TargetsIntegrin alpha-V/beta-3
Therapy Area/IndicationsCoronary Artery DiseaseStrokeArthritis, Rheumatoid +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesChinese Academy Of Medical Science & Peking Union Medical CollegePeking Union Medical College Hospital
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPeking Union Medical College Hospital
Active IndicationsN/A
Inactive IndicationsCoronary Artery DiseaseStrokeArthritis, Rheumatoid +[5] 

Other Information

ATC CodeN/A
Related LinksN/A